External validation of exacerbation and mortality outcomes of health economic decision models for COPD Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016
COPD admissions and inhaled medications: Escalating prescription costs but no evidence of effect. A national primary care study Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care Year: 2013
Asthma severity and medical resource utilisation Source: Eur Respir J 2004; 23: 723-729 Year: 2004
Effectiveness of montelukast on asthma control in infants: A claims data study Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015
Asthma severity, poor control, co-morbidities and prior resource use determined omalizumab prescriptions in a nested case-control study with US claims data Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015
Health care cost associated with acute and stable asthma: an economic analysis Source: Eur Respir J 2003; 22: Suppl. 45, 418s Year: 2003
Childhood asthma: healthcare resource utilisation in those with and without a diagnosis of the condition Source: Eur Respir J 2003; 22: Suppl. 45, 355s Year: 2003
Late Breaking Abstract - Assessing epidemiology and costs of asthma and COPD in Switzerland with health insurance data Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs Year: 2018
Global asthma network survey of national asthma strategies – Where are the gaps? Source: International Congress 2016 – Clinical studies in asthma and immunology Year: 2016
Health care costs associated with acute asthma: a economic analysis Source: Eur Respir J 2002; 20: Suppl. 38, 42s Year: 2002
Characterizing healthcare resource utilization by GINA steps in asthma patients Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies Year: 2019
Global asthma network identifies gaps in essential asthma medicines Source: International Congress 2016 – Clinical studies in asthma and immunology Year: 2016
Does an mHealth system reduce health service use for asthma? Source: ERJ Open Res, 6 (3) 00340-2019; 10.1183/23120541.00340-2019 Year: 2020
Persistence to COPD therapies and impact on exacerbations: a French claims data study Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections Year: 2018
Validity and interpretation of mortality, health service and survey data on COPD and asthma in England Source: Eur Respir J 2003; 21: 279-286 Year: 2003
Asthma management and utilization of healthcare services in children: the results of a population-based survey Source: Eur Respir J 2001; 18: Suppl. 33, 146s Year: 2001
Profiling hospital performance to monitor the quality of care: the case of COPD Source: Eur Respir J 2010; 35: 1031-1038 Year: 2010
Relative exposure to inhaled steroids (ratio "ICS-to-total asthma therapy"): Concordant data from electronic medical records, claims data and patient-reported outcomes Source: Annual Congress 2012 - Healthcare utilisation and treatment of asthma and COPD Year: 2012
Title: The effect of COPD pay-for-performance program on healthcare resource utilization in Taiwan Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases Year: 2021
Evidence of variation to drive quality improvement: The NHS atlas of variation in respiratory healthcare Source: Annual Congress 2013 –Is it really asthma? Year: 2013